Whether to do the Sovigripp vaccine for children

2024 Author: James Gerald | [email protected]. Last modified: 2024-01-12 17:37

"Sovigripp" is an excellent tool for preventing the disease with the influenza virus, the likelihood of which is due to the unformed immunity of childhood and the specificity of the transmission of a dangerous infection.

The vaccine for children is produced by the domestic pharmaceutical industry and, judging by the reviews of well-known pediatricians, is safe and effective. The well-known specialist E. Komarovsky has repeatedly expressed the need for vaccination.

Goals and means

Immunization is one of the main achievements of medicine in the entire history of its existence. Precisely preventive vaccinations have made it possible to defeat many dangerous diseases that have claimed millions of human lives for centuries. Statistical studies in the United States, where the mandatory vaccination against certain diseases was recently introduced, showed that about 108 million cases of disease are prevented in the country thanks to vaccinations every year, and according to the WHO, 3 million deaths are avoided on the planet.

For vaccination in medicine, the most variable types of drugs are used, developed by virologists, immunologists, genetic engineers and molecular biologists.

In order to protect a person from possible infection, live and inactivated compounds, toxoids prepared at the molecular level, products of genetically engineered modification and replication, and chemical compounds are used.

For children, monovaccines and multicomponent (associated) vaccines can be used simultaneously, which contain ready-made antibodies to infection or its ingredients that stimulate the immune system.

Positive sides

"Sovigripp" - the name of the drug against the influenza virus, which belongs to the group of special anti-influenza inactivated (safe for children) drugs. It is processed annually, according to the recommendations of the WHO and the instructions of the Ministry of Health of Russia, based on information obtained on the distribution and suspected activity of different types of viruses.

A good opinion about the work of the drug against a dangerous viral infection can be the fact that the vaccine is produced and purchased under the state program and supplied to preschool educational institutions, children's district polyclinics, and schools.

"Sovigripp" has become the subject of preference in the state program due to repeated testing in clinical conditions and the proven reputation of the manufacturer.

A children's doctor from Kharkov, Yevgeniy Komarovsky, noted that, despite the absence of a vaccine for children in the mandatory list of vaccinations, the use of drugs to prevent influenza from the group to which Sovigripp belongs will save parents money spent on the treatment and rehabilitation of a child after an infection.

Reviews of other experts indicate the relevance of the use of the Russian drug. This position in the list of leaders is maintained thanks to the annual transformations in the basic composition, which are necessary due to the diversity of types of influenza viruses and their ability to quickly mutate. Recommendations for changes are annually disseminated by WHO, which makes predictions about probable types of influenza based on permanent monitoring of the pathogenic agent.

Dr. Komarovsky focused the attention of parents on the fact that each type of vaccine for children can lead to a natural reaction of the body to an intramuscular injection. This is the process by which antibodies are made.

It is accompanied by a typical set - from a short-term rise in temperature to pain and redness in the tissue. However, Komarovsky is not only sure of the need for such a step, but also insists on a two-time event if the baby is vaccinated for the first time in his life.

Experts' comments on the use of Sovigrippa are invariably favorable. But the most positive aspect of this vaccine for children is not considered to be the possible prevention of illness or relief of the condition if the child does contract the flu, but the chance to protect him from the most common types of the virus. After all, it is their subtypes and strains that can lead to unpredictable and serious consequences.

Composition and prerogatives

The well-known pediatrician E. Komarovsky has repeatedly spoken out about influenza vaccination. He is convinced that vaccinations should be done, despite possible reactions, if the child has no contraindications. The only reservation concerns children under one year old - in this case, it is better to vaccinate parents and people who come into contact with the baby.

Children who visit preschool educational institutions, according to Komarovsky, need to be vaccinated in advance - messages about the expected epidemic are always published in advance, and it is necessary to apply the influenza vaccine for children no later than two weeks before the start of the unfavorable period.

The basic composition of Sovigrippa invariably contains specific surface viral proteins known as influenza virus glycoproteins, but this does not pose an immediate danger to the child's body, since they go through several stages during the preparation process:

• first, chicken embryos are infected with a viral infection, which are used as the most optimal medium for obtaining vaccinated fluid;
• then the resulting virus particles A and B are neutralized and purified;
• in the genetic engineering laboratory, glycoproteins are extracted from them, which are used as a base composition for the production of Sovigrippa;
• the manufacturer produces two types of the drug, one of which contains a preservative, however, as a vaccine for children, only Sovigripp is used without thiomersal, adults are allowed to use both types.

The parents' comments indicate that at the injection site (it is done only intramuscularly), the child shows standard reactions - slight hyperemia of the skin and slight swelling, a slight reaction of the mucous membrane in the form of a short-term runny nose. There are mild signs of the presence of a viral infection - weakness, lethargy, headache and low-grade fever.

Dr. Komarovsky is sure that such manifestations of the vaccine's action are much easier to endure than a real viral infection with its severe intoxication and unpredictable consequences. Instead of bed rest and prolonged discomfort, the discomfort will last 1 - 2 days.

Reviews

Galina Vyazovskaya, Moscow region

“We were vaccinated with Sovigrippa in mid-September, and my son really showed symptoms that resemble a mild cold. This is not the first year that we have been vaccinating him against the flu, thanks for prompting us a way out, since he spent 2 - 3 weeks of winter in bed."

Family Mateyko, Samara

"Every year we vaccinate the entire family and are surprised at the dimness of those who believe that it is necessary to give it up. In our family, no one gets the flu. While the children were small, they even combined the influenza vaccine with routine vaccinations. About Sovigripp, the instructions say, that it is compatible with any means other than antirabies, just injections are given in different parts of the body."

Elena Romanova, St. Petersburg

“I am a pediatrician with 20 years of experience. In my memory, only 1 child out of 10 develops a pronounced adverse reaction from Sovigrippa, and almost always this is the result of medical or parental negligence. The child is vaccinated after a recent illness or is not paying attention to his painful condition."

Bonus

Vaccination against influenza in a risk group or in a large group of children is an event that provides undeniable benefits:

1. The child is protected from the potential danger of infection, and if he has the flu, then in a mild form.
2. "Sovigripp" is a proven vaccine from a domestic manufacturer that has repeatedly proven its effectiveness.
3. Minor manifestations are a natural reaction of the immune system that produces antibodies.
4. Vaccination during the cold season will protect the child from severe viral infection.